Table 4.
Univariate analysis to assess the impact of dose factors on the appearance of CTCAE grad II-III toxicity and moist desquamation in 276 patients
| Variables | CTCAE | Moist Desquamation | ||||
|---|---|---|---|---|---|---|
| I° | II°/III° | P value | No | Yes | P value | |
| Dmax CTV (Gy) | 52.9 (50.0–59.8) | 52.9 (47.7–61.8) | 0.91 | 52.9 (50.0–61.84) | 53.1 (47.7–55.5) | 0.34 |
| Dmax skin (Gy) | 53.3 (50.2–60.1) | 53.4 (48.4–62.1) | 0.64 | 52.4 (47.9–61.0) | 52.6 (47.6–54.2) | 0.93 |
| Dmean skin (Gy) | 36.5 (23.0–38.7) | 36.6 (19.8–38.9) | 0.66 | 36.6 (19.8–38.7) | 36.4 (20.5–38.9) | 0.10 |
| V107% CTV (cm3) | 0.4 (0.0–79.0) | 0.8 (0–45.8) | 0.54 | 0,6 (0–79.0) | 1.3 (0–45.8) | 0.04* |
| V105% Skin (cm3) | 0.3 (0.0–8.7) | 0.6 (0.0–46.5) | 0.27 | 0.4 (0.0–17.2) | 0.9 (0.0–46.5) | 0.03* |
| V80% Skin (cm3) | 124.7 (35.3–293.9) | 134.3 (5.9–282.6) | 0.06 | 126.9 (5.9–293.9) | 147.7 (67.9–282.6) | < 0.01* |
Mean values ± SD. *p < 0.05